The study aims to investigate different approaches of local application of antibiotics/antiseptics intraoperatively in Chinese patients undergoing post-mastectomy implant based breast reconstruction, and aims to single out an intervention method that limits the use of antibiotics and maintains low rates of surgical site infection and capsular contracture. Patients who undergo post mastectomy breast reconstruction in the breast reconstruction department in Tianjin Medical University Cancer Institute and Hospital are eligible to enter the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Occurrence of minor surgical site infection
Timeframe: assessed up to 3 months post-op
Occurrence of major surgical site infection
Timeframe: assessed up to 3 months post-op
Occurrence of capsular contracture
Timeframe: assessed from 3 months post-op up to 2 years post-op or until the trial ends, whichever comes first